Furthermore, the concentration of serum IL-21, which is an effector molecular of cTfh cells, was a positive trend of the correlation with the H-Y stage and UPDRS-III score in PD patients, suggesting that IL-21 may be used as a marker to assess the severity of the disease. Here, IL21 is linked to Parkinson disease.